Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Cantopher, T.
Olivieri, S.
Cleave, N.
and
Edwards, J. Guy
1990.
Chronic Benzodiazepine Dependence.
British Journal of Psychiatry,
Vol. 156,
Issue. 3,
p.
406.
Murphy, Siobhan M.
and
Tyrer, Peter
1991.
A Double-Blind Comparison of the Effects of Gradual Withdrawal of Lorazepam, Diazepam and Bromazepam in Benzodiazepine Dependence.
British Journal of Psychiatry,
Vol. 158,
Issue. 4,
p.
511.
Garcia-Borreguero, D.
Bronisch, T.
Apelt, S.
Yassouridis, A.
and
Emrich, H. M.
1991.
Treatment of benzodiazepine withdrawal symptoms with carbamazepine.
European Archives of Psychiatry and Clinical Neuroscience,
Vol. 241,
Issue. 3,
p.
145.
Edwards, J Guy
1992.
Medicolegal aspects of benzodiazepine dependence: Duties and responsibilities of doctors.
Medical Journal of Australia,
Vol. 156,
Issue. 10,
p.
733.
Roy-Byrne, Peter P.
Sullivan, Mark D.
Cowley, Deborah S.
and
Ries, Richard K.
1993.
Adjunctive treatment of benzodiazepine discontinuation syndromes: A review.
Journal of Psychiatric Research,
Vol. 27,
Issue. ,
p.
143.
ASHTON, HEATHER
1994.
The treatment of benzodiazepine dependence.
Addiction,
Vol. 89,
Issue. 11,
p.
1535.
Vgontzas, A. N.
and
Kales, A.
1995.
The Pharmacology of Sleep.
Vol. 116,
Issue. ,
p.
503.
Woods, James H.
and
Winger, Gail
1995.
Current benzodiazepine issues.
Psychopharmacology,
Vol. 118,
Issue. 2,
p.
107.
Ramon, Shulamit
1996.
Mental Health in Europe.
p.
98.
Cassano, GB
Petracca, A
Borghi, C
Chiroli, S
Didoni, G
and
Garreau, M
1996.
A randomized, double-blind study of alpidem vs placebo in the prevention and treatment of benzodiazepine withdrawal syndrome.
European Psychiatry,
Vol. 11,
Issue. 2,
p.
93.
Johansson, Björn Axel
Berglund, Mats
and
Frank, Arne
1997.
Effects of gradual benzodiazepine taper during a fixed 10-day schedule: A pilot study.
Nordic Journal of Psychiatry,
Vol. 51,
Issue. 4,
p.
281.
Lemoine, Patrick
and
Ohayon, Maurice M.
1997.
Is hypnotic withdrawal facilitated by the transitory use of a substitute drug?.
Progress in Neuro-Psychopharmacology and Biological Psychiatry,
Vol. 21,
Issue. 1,
p.
111.
Romach, Myroslava K.
Kaplan, Howard L.
Busto, Usoa E.
Somer, Gail
and
Sellers, Edward M.
1998.
A Controlled Trial of Ondansetron, a 5-HT3 Antagonist, in Benzodiazepine Discontinuation.
Journal of Clinical Psychopharmacology,
Vol. 18,
Issue. 2,
p.
121.
Pokk, P
1998.
Small platform stress attenuates the anxiogenic effect of diazepam withdrawal in the plus-maze test.
Behavioural Brain Research,
Vol. 97,
Issue. 1-2,
p.
153.
Schweizer, E.
and
Rickels, K.
1998.
Benzodiazepine dependence and withdrawal: a review of the syndrome and its clinical management.
Acta Psychiatrica Scandinavica,
Vol. 98,
Issue. s393,
p.
95.
ROCHE, ANN M.
WATT, KERRIANNE
and
FISCHER, JANE
2001.
General Practitioners' views of home detoxification.
Drug and Alcohol Review,
Vol. 20,
Issue. 4,
p.
395.
Faravelli, C.
Rosi, S.
and
Truglia, E.
2002.
Anxiety Disorders.
p.
313.
Mercier-Guyon, C.
Chabannes, J. P.
and
Saviuc, P.
2004.
The role of captodiamine in the withdrawal from long-term benzodiazepine treatment.
Current Medical Research and Opinion,
Vol. 20,
Issue. 9,
p.
1347.
Wolter, Dirk K.
2006.
Sucht im Alter.
Zeitschrift für Gerontopsychologie & -psychiatrie,
Vol. 19,
Issue. 4,
p.
189.
Voshaar, Richard C. Oude
Couvée, Jaap E.
Van Balkom, Anton J. L. M.
Mulder, Paul G. H.
and
Zitman, Frans G.
2006.
Strategies for discontinuing long-term benzodiazepine
use.
British Journal of Psychiatry,
Vol. 189,
Issue. 3,
p.
213.
eLetters
No eLetters have been published for this article.